Colonia Care Pharmacy Recalls C-MB12 NAC Injection Syringes for Sterility Concerns
Colonia Care Pharmacy is recalling 15 syringes of C-MB12 NAC injection solution because the product's sterility cannot be guaranteed. The recall affects patient-specific prescriptions in New Jersey.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II, and the hazard involves a lack of assurance of sterility in an injectable product, which poses a significant risk of infection or serious injury.
Plain-English summary
Colonia Care Pharmacy is recalling 15 syringes of C-MB12 NAC 13MG/48MG/ML INJ SOLN, 0.29 mL in a 0.3 mL syringe. The recall is due to a lack of assurance of sterility, meaning the product's sterility cannot be guaranteed.
The affected product is identified by Lot # 070919C with a beyond-use date of 08/23/19. The recall covers patient-specific prescriptions distributed in New Jersey.
Consumers who have this product should stop using it and contact their healthcare provider or the pharmacy for further instructions.
The recalled product
- Product
- C-MB12 NAC 13MG/48MG/ML INJ SOLN, 0.29 mL in a 0.3 mL syringe, Rx only, Colonia Care Pharmacy, 515 Inman Ave., Suite A, Colonia, N.J. 07067
- Manufacturer
- Colonia Care Pharmacy
- Category
- Drug — Injectable Solution
- Affected units
- 15
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 070919C
- BUD 08/23/19
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 32 recalled by Colonia Care Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 32 products in this recall →Related recalls
Same manufacturer · Colonia Care Pharmacy
See all →- SevereColonia Care Pharmacy Recalls C-Papav/Phentol/PGE1 Vials Due to Sterility Concerns
FDA (Drugs) · 2019-10-09
- SevereColonia Care Pharmacy Recalls Gentamicin Injection Due to Sterility Concerns
FDA (Drugs) · 2019-10-09
- SevereColonia Care Pharmacy Recalls C-Papav/Phentol/PGE1 Vials for Sterility Concerns
FDA (Drugs) · 2019-10-09
- SevereColonia Care Pharmacy Recalls Verapamil Injection Due to Sterility Concerns
FDA (Drugs) · 2019-10-09
- SevereColonia Care Pharmacy Recalls Sterility-Compromised C-Papav/Phentol/PGE1 Vials
FDA (Drugs) · 2019-10-09
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereColonia Care Pharmacy Recalls Injectable Drug Products Due to Sterility Concerns
FDA (Drugs) · 2016-12-28
- SevereAssurance Infusion Recalls Clonidine and Morphine Injection Due to Sterility Concerns
FDA (Drugs) · 2020-01-22
- HighMIC/B12 Injectable Vials Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2022-09-21
- SevereAssurance Infusion Recalls Clonazepam and Morphine Injection Due to Sterility Concerns
FDA (Drugs) · 2020-01-22
- SevereCMC Enterprise Pharmacy Recalls CefTRIAXone Syringes Due to Sterility Concerns
FDA (Drugs) · 2019-05-01
- SevereKey Pharmacy Recalls GSH/NAC Inhalation Solution Due to Sterility Concerns
FDA (Drugs) · 2017-05-24